Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
3.490
-0.250 (-6.68%)
At close: Mar 9, 2026, 4:00 PM EDT
3.550
+0.060 (1.72%)
After-hours: Mar 9, 2026, 4:41 PM EDT
Nyxoah Employees
Nyxoah had 184 employees as of December 31, 2024. The number of employees increased by 37 or 25.07% compared to the previous year.
Employees
184
Change (1Y)
37
Growth (1Y)
25.07%
Revenue / Employee
$36,036
Profits / Employee
-$535,019
Market Cap
149.39M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AngioDynamics | 675 |
| OraSure Technologies | 501 |
| Pro-Dex | 181 |
| Utah Medical Products | 167 |
| Sanara MedTech | 141 |
| Stereotaxis | 139 |
| KORU Medical Systems | 80 |
| Sharps Technology | 55 |
NYXH News
- 19 days ago - Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East - GlobeNewsWire
- 6 weeks ago - Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewsWire
- 2 months ago - Publication relating to transparency notification - GlobeNewsWire
- 2 months ago - Nyxoah Announces Issuance of First Tranche of Convertible Bonds - GlobeNewsWire
- 2 months ago - Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands - GlobeNewsWire
- 3 months ago - Publication relating to transparency notifications - GlobeNewsWire
- 3 months ago - Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule - GlobeNewsWire